Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 10:54 am Sale |
2025-03-11 | 13G | 2seventy bio, Inc. TSVT |
Kynam Capital Management, LP | 0 0.000% |
-5,953,825 (Position Closed) |
Filing History |
| 2025-02-14 5:18 pm Purchase |
2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Kynam Capital Management, LP | 8,520,000 9.980% |
2,860,000 (+50.53%) |
Filing History |
| 2025-02-14 5:16 pm Purchase |
2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN |
Kynam Capital Management, LP | 4,994,090 9.800% |
4,994,090 (New Position) |
Filing History |
| 2025-02-14 5:16 pm Sale |
2024-12-31 | 13G | Dynavax Technologies Corporation DVAX |
Kynam Capital Management, LP | 6,560,835 4.990% |
-1,771,852 (-21.26%) |
Filing History |
| 2025-02-14 5:16 pm Purchase |
2024-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Kynam Capital Management, LP | 5,064,207 7.630% |
2,058,303 (+68.48%) |
Filing History |
| 2024-11-14 12:29 pm Purchase |
2024-09-30 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 989,217 12.020% |
119,774 (+13.78%) |
Filing History |
| 2024-11-14 12:24 pm Purchase |
2024-09-30 | 13G | Cogent Biosciences, Inc. COGT |
Kynam Capital Management, LP | 9,239,731 8.360% |
3,384,965 (+57.82%) |
Filing History |
| 2024-11-14 12:18 pm Purchase |
2024-09-30 | 13G | Dynavax Technologies Corporation DVAX |
Kynam Capital Management, LP | 8,332,687 6.340% |
8,332,687 (New Position) |
Filing History |
| 2024-11-14 12:15 pm Sale |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 1,576,549 2.490% |
-2,073,790 (-56.81%) |
Filing History |
| 2024-03-08 3:58 pm Purchase |
2024-02-29 | 13G | MorphoSys AG MOR |
Kynam Capital Management, LP | 4,190,331 11.130% |
500,000 (+13.55%) |
Filing History |
| 2024-02-14 12:53 pm Sale |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Kynam Capital Management, LP | 0 0.000% |
-2,025,234 (Position Closed) |
Filing History |
| 2024-02-14 12:52 pm Purchase |
2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Kynam Capital Management, LP | 3,005,904 5.500% |
3,005,904 (New Position) |
Filing History |
| 2024-02-14 12:51 pm Purchase |
2023-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Kynam Capital Management, LP | 5,854,766 6.800% |
5,854,766 (New Position) |
Filing History |
| 2024-02-14 12:50 pm Purchase |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Kynam Capital Management, LP | 5,660,000 6.670% |
5,660,000 (New Position) |
Filing History |
| 2024-02-14 12:49 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 3,650,339 8.220% |
2,241,241 (+159.06%) |
Filing History |
| 2024-02-14 12:47 pm Purchase |
2023-12-31 | 13G | MorphoSys AG MOR |
Kynam Capital Management, LP | 3,690,331 9.800% |
3,690,331 (New Position) |
Filing History |
| 2024-02-14 12:45 pm Unchanged |
2023-12-31 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 869,443 10.190% |
0 (Unchanged) |
Filing History |
| 2024-01-10 4:08 pm Purchase |
2023-12-31 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 869,443 10.190% |
130,285 (+17.63%) |
Filing History |
| 2023-09-06 4:54 pm Purchase |
2023-08-31 | 13G | 2seventy bio, Inc. TSVT |
Kynam Capital Management, LP | 5,953,825 11.700% |
5,953,825 (New Position) |
Filing History |
| 2023-03-21 5:40 pm Sale |
2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Kynam Capital Management, LP | 2,025,234 5.000% |
-38,398,598 (-94.99%) |
Filing History |